MHY908
货号：
18293-10mg 基本售价：
6860.0 元 规格：
10 mg
产品信息
概述| 货号 | 18293-10mg |
| 描述 | Peroxisome proliferator-activated receptors (PPARs) are activated by fatty acids and eicosanoids as well as antidyslipidemic agents. Among the receptor isotypes, PPARα demonstrates a particular role in fatty acid oxidation, whereas PPARγ is known to be involved in adipocyte differentiation and lipid storage. MHY908 is a dual agonist of PPARα and PPARγ.1 MHY908 has been shown to enhance the binding and transcriptional activity of PPARα and PPARγ in AC2F cells (5 µM) more potently than fenofibrate (Item No. 10005368) or rosiglitazone (Item No. 71740) and to reduce serum glucose, triglyceride, and insulin levels in db/db mice (3 mg/kg).1 It is also reported to improve hepatic steatosis by enhancing CPT1 levels and to reduce endoplasmic reticulum stress and JNK activation in the livers of db/db mice, leading to reduced insulin resistance.1 |
性能| 供应商 | Cayman |
| 应用文献 |
1.Park, M.H.,Park, J.Y.,Lee, H.J., et al. Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice. PLoS One 8(11), e78815 (2013).
|
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 347.8 |
| 分子式 | C17H14ClNO3S |
| CAS号 | 1393371-39-5 |
| 稳定性 | ≥ 2 years |
声明| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
